Stockscreener 앱 받기
0.7025
0.36%
0.0025
시장 영업 전:
.70
-0.0025
-0.36%
전일 마감가:
$0.70
열려 있는:
$0.6914
하루 거래량:
3.13M
Relative Volume:
0.85
시가총액:
$208.85M
수익:
-
순이익/손실:
$-63.08M
주가수익비율:
-2.6019
EPS:
-0.27
순현금흐름:
$-72.53M
1주 성능:
-1.78%
1개월 성능:
+1.75%
6개월 성능:
-26.68%
1년 성능:
-61.19%
1일 변동 폭
$0.671
$0.7175
1주일 범위
$0.65
$0.735
52주 변동 폭
$0.515
$2.06
오큐젠 Stock (OCGN) Company Profile
명칭
Ocugen Inc
전화
484-328-4701
주소
11 GREAT VALLEY PARKWAY, MALVERN, PA
OCGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
0.7025 | 208.85M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.00 | 115.57B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.16 | 60.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
542.47 | 37.56B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.86 | 35.18B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
224.73 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
오큐젠 Stock (OCGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-15 | 개시 | Maxim Group | Buy |
| 2023-03-01 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | 개시 | Mizuho | Buy |
| 2022-06-15 | 재개 | ROTH Capital | Buy |
| 2022-06-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-07-26 | 개시 | Noble Capital Markets | Outperform |
| 2021-06-11 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-05-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
모두보기
오큐젠 주식(OCGN)의 최신 뉴스
Ocugen to Host Q1 2025 Earnings Call and Business Update on May 9 - MSN
Ocugen stock price target cut to $7 by H.C. Wainwright - Investing.com Nigeria
Ocugen (OCGN) Price Target Reduced by H.C. Wainwright | OCGN Sto - GuruFocus
Ocugen (OCGN) Maintains 'Buy' Rating Despite Price Target Adjust - GuruFocus
Ocugen (OCGN) Receives Ongoing "Buy" Rating from Chardan Capital - GuruFocus
The Analyst Verdict: Ocugen In The Eyes Of 5 Experts - Benzinga
Ocugen outlines 2025 milestones for gene therapy programs with BLA filings on track - MSN
Ocugen, Inc. (NASDAQ:OCGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Ocugen: Q1 Earnings Snapshot - San Francisco Chronicle
Ocugen Inc (OCGN) Q1 2025 Earnings Call Highlights: Strategic Advances in Gene Therapy Amid ... - Yahoo
Earnings call transcript: Ocugen’s Q1 2025 loss narrows, stock rises By Investing.com - Investing.com India
Ocugen Inc (OCGN) Q1 2025 Earnings Call Highlights: Strategic Advances in Gene Therapy Amid ... By GuruFocus - Investing.com Canada
Earnings call transcript: Ocugen’s Q1 2025 loss narrows, stock rises - Investing.com
Ocugen’s Q1 2025: Progress in Gene Therapy Trials - TipRanks
Ocugen Inc’s Earnings Call: Optimism Amid Financial Challenges - TipRanks
Ocugen Provides Business Update with First Quarter 2025 Financia - GuruFocus
Ocugen Q1 2025 Earnings Call Transcript - MarketBeat
Ocugen (OCGN) Reveals Strong Q1 Revenue Growth and Strategic Cli - GuruFocus
Ocugen Provides Business Update with First Quarter 2025 Financial Results - Ocugen
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish By Stocktwits - Investing.com India
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish - MSN
Ocugen (OCGN) Set to Release Q1 Earnings with Minimal Revenue Ex - GuruFocus
A Look at Ocugen's Upcoming Earnings Report - Nasdaq
Ocugen (OCGN) Set to Release Q1 Earnings with Minimal Revenue Expectations - GuruFocus
Ocugen to Showcase Gene Therapy Advances at Upcoming Ophthalmology Conferences - MSN
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET - GuruFocus
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results | OCGN Stock News - GuruFocus
Ocugen, Inc. to Host Conference Call for Q1 2025 Financial Results and Business Update - Nasdaq
Ocugen to Host Conference Call on Friday, May 9 at 8:30 - GlobeNewswire
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results - TradingView
Gene Therapy Pioneer Ocugen Sets Q1 2025 Earnings Call to Reveal Blindness Treatment Progress - Stock Titan
Ocugen to Present at Eyecelerator Conference May 2025 - TipRanks
Ocugen to Present on Modifier Gene Therapy Platform at Associati - GuruFocus
OCUGEN Earnings Preview: Recent $OCGN Insider Trading, Hedge Fund Activity, and More - Nasdaq
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress - Ocugen
Stock Quote & Chart - Ocugen
Ocugen, Inc. to Showcase Innovative Modifier Gene Therapy Platform at Upcoming ARVO and Retina World Congress Meetings - Nasdaq
Ocugen to Present on Modifier Gene Therapy Platform at - GlobeNewswire
Revolutionary Gene Therapy Platform: Ocugen Presents Phase 3 Trial Results for Multiple Eye Diseases - Stock Titan
O’Reilly Automotive: An Anytime Buy for Buy-and-Hold Investors - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Form DEF 14A Ocugen, Inc. For: Jun 05 - StreetInsider
Ocugen, Inc. Announces Directorate Resignations - marketscreener.com
오큐젠 (OCGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
오큐젠 주식 (OCGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Castillo Kirsten | Director |
Nov 22 '24 |
Buy |
0.91 |
25,000 |
22,848 |
75,000 |
3.01%
자본화:
|
볼륨(24시간):